Gert Storm studied biology at the Utrecht University, The Netherlands, and obtained his PhD degree in 1987 at the Department of Pharmaceutics of the same university. He is now Professor of targeted drug delivery at the University of Utrecht, as well as Professor of targeted therapeutics at the MIRA institute of the University of Twente (Enschede, The Netherlands). He also holds a position at the University Medical Center Utrecht within the Centre for Image-Guided Oncological Interventions. Among various other commitments, Professor Storm is Director of the Drug Delivery program embedded within the new nano initiative, titled NanoNextNL, a member of the Board of Scientific Advisors of the Controlled Release Society, and a Scientific Board member of Enceladus Pharmaceuticals BV, a spin-off company based in Amsterdam (The Netherlands). Gert Storm spoke to Therapeutic Delivery regarding his career to date, his research within the targeted drug-delivery field, and the obstacles that need to be tackled in order to advance this exciting research area.